Elon Musk aims to conquer a new frontier. No, I donât mean outer space, the focus of his SpaceX venture. And Iâm not referring to social media, where he made a giant splash last year in acquiring Twitter (now known as âXâ). Interestingly, the frontier Iâm talking about isnât very big. In fact, itâs the [â¦] You're receiving this email as part of your subscription to Michael Robinsonâs Trend Trader Daily [Unsubscribe](. [Trend Trader Daily] The Critical Technology Powering Elonâs Next Venture October 24, 2023 Elon Musk aims to conquer a new frontier. No, I donât mean outer space, the focus of his SpaceX venture. And Iâm not referring to social media, where he made a giant splash last year in acquiring Twitter (now known as âXâ). Interestingly, the frontier Iâm talking about isnât very big. In fact, itâs the space right between your ears. Itâs an area that Musk aims to conquer with what could become his most valuable enterprise... And today, Iâll reveal how we can position ourselves to profit from its success. > ADVERTISEMENT < GM's next big release has no engine and no wheels In a shocking move, auto giant General Motors is venturing into a whole new space (hint: NOT electric vehicles). While industry analysts see this as a way of catching up with Tesla, the bigger reason could be because this new space is getting the full backing of the current administration and could mean huge tax credits in the future. Or it could just be that this fledgling industry has more scope than the declining auto industry. Whatever it may be, this move could put GM into the same bracket as Apple, Google, Microsoft, and Amazon. [Get the details of this massive trend here](. Musk Wants Inside Your Head Perhaps youâve heard of Muskâs urge to get inside your head. And I do mean that literally. You see, seven years ago, Musk founded Neuralink, a neurotechnology company with a focus on neuroscience, biochemistry, and robotics. Of course, with Musk, itâs always about the âbig ideaâ â like landing a man on Mars (SpaceX), building a self-driving car (Tesla), or creating a network of underground tunnels (The Boring Company). And that was certainly true with Neuralink. You see, Neuralink is developing implantable brain-computer interfaces (âBCIsâ), tiny devices that act as direct communication links between the brainâs electrical activity and an external device â a computer or robotic limb, for example. Hereâs a picture of what the device might look like: Essentially, a tiny coin-sized chip called the Link (shown on the right) will be inserted under the skull. From this chip, dozens of hair-thin wires will be extended into the brain. These wires will both read brain activity and send signals. And each one is so thin and flexible, no human could possibly insert them... Which is why Neuralink has also developed a fully-autonomous surgical robot that will handle installation. A battery outside the skull will be used to power the chip. If it seems like something from a science-fiction novel, youâre on the right track. Musk got the idea for these implants partly from a popular sci-fi book series called âThe Culture.â But these implants could really happen... And their potential impact could be life-changing. Potential Impact Consider, for example, those suffering from Parkinsonâs Disease, a group Neuralink aims to initially target. Parkinsonâs is a brain disorder that causes unintended or uncontrollable movements. Over time, people may lose the ability to move or talk altogether. BCIs like Neuralinkâs could correct signals sent from the brain to the body, bridging any gaps caused by the disease and removing noise from the signal. Globally, an estimated 1.2 billion people either are, or will be, afflicted with Parkinsonâs. The global market for treating and addressing this disease is projected to surpass $17 billion in ten years. Of course, not every Parkinsonâs sufferer will qualify for a Neuralink implant. But this device could help other types of patients... For example, paralysis could be cured by having the implant bridge the gap between the brain and body. And those battling depression, schizophrenia, and other conditions could benefit from the implant correcting abnormal brain signaling. But before these implants can get anywhere near the open market, they must first undergo extensive testing. That includes clinical trials involving human volunteers. Any Volunteers? You see, Musk is seeking volunteers for an upcoming clinical trial. Neuralink received approval for this trial from the Food and Drug Administration (âFDAâ) back in May, but no details were revealed at the time. Today, we know the company will implant BCIs into patients who have suffered paralysis below the neck and monitor them for six years. Initially, Neuralink will aim to enable patients to type on a computer using only their thoughts. And the mind-control possibilities extend from there. The potential of this technology is why Neuralink is already a valuable enterprise. On the heels of clinical-trial approval, the company raised $280 million in a round led by tech billionaire Peter Thielâs Founders Fund. Even before this round, Neuralink was valued at $5 billion. Investors like Thiel could wind up with a windfall of profits one day. And Iâd love for us to join him. Unfortunately, Neuralink isnât raising any funds from individual investors like us â at least, not right now. No matter, though... Iâve got a way we can invest in the technology behind this companyâs implants and still position ourselves for profits. Let me explain... A Critical Technology You see, thereâs an important technology that Neuralinkâs BCIs canât work without. Iâm talking about microcontrollers â tiny, all-in-one computers housed on a single chip. These controllers read their environments for changes in movement, temperature, and pressure. And they wait for signals sent via sound, light, or Wi-Fi to control small motors and radios. Microcontrollers are everywhere â from water pumps to television clickers to childrenâs toys. Theyâre also in medical devices, fighter jets, satellites, missiles, and almost anything else you can think of. In Neuralinkâs implant, all the signal processing that enables the device to read what the brain is doing and respond is thanks to microcontrollers. With that in mind, letâs focus on a company thatâs a leader in the microcontroller sector. Iâve saved the details for âProâ readers, so donât miss out. â FOR TREND TRADER PRO READERS ONLY
> [LEARN MORE]( < Cheers and Good Investing, [Michael Robinson]
Michael Robinson
Chief Investment Officer
Trend Trader Daily â Copyright © Trend Trader Daily, All rights reserved. You signed up on
[]( Our mailing address is:
Trend Trader Daily
1125 N. Charles Street
Baltimore, Maryland 21201
[Update Subscription Preferences]( | [Unsubscribe from this list]( RISK NOTICE: All investing comes with risk. That includes the investments teased in this letter. You should never invest more than you can afford to lose. Please use this research for the purpose that it's intended â as research only. You should consult a professional financial advisor before ever taking a position in any securities you see herein. DISCLAIMERS: The work included in this communication is based on diverse sources including SEC filings, current events, interviews, corporate press releases, and information published on funding platforms, but the views we express and the conclusions we reach are our own. As such, this content may contain errors, and any investments described in this content should be made only after reviewing the filings and/or financial statements of the company, and only after consulting with your investment advisor. Actual results may differ significantly from the results described herein. Furthermore, nothing published by Trend Trader Daily, Inc should be considered personalized financial advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized investment advice. Trend Trader Daily is an independent provider of education, information and research on publicly traded companies, and as such, it accepts no direct or indirect compensation from any companies or third parties mentioned in any of our letters, reports or updates.